Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Methotrexate therapy
DRUG
2 trials
Sponsors
Astellas Pharma Inc
, National Medical Research Center for Children's Health, Russian Federation
Conditions
Atopic Dermatitis
Rheumatoid Arthritis (RA)
Phase 2
A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate
Completed
NCT03257852
Astellas Pharma Inc
Rheumatoid Arthritis (RA)
Start: 2017-09-29
End: 2018-10-16
Updated: 2024-10-31
Phase 4
Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood
NCT04895423
National Medical Research Center for Children's Health, Russian Federation
Atopic Dermatitis
Start: 2021-11-25
End: 2023-07-25
Target: 160
Updated: 2021-05-20
Related Papers
ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial.
2020-10-21
11 citations